Global Deep Vein Thrombosis Market Size By Treatment (Clot Busters, Blood Thinners), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy), By Geographic Scope And Forecast

Deep Vein Thrombosis Market Size And Forecast

Deep Vein Thrombosis Market size was valued at USD 1.11 Billion in 2024 and is projected to reach USD 1.48 Billion by 2031, growing at a CAGR of 3.96% during the forecast period 2024-2031.

The global Deep Vein Thrombosis Market is largely driven by an increasing prevalence of obesity across the global population. Lifestyle changes and unhealthy eating habits are major factors resulting in obesity, causing the accumulation of excessive fat and cholesterol. This surges the likelihood of getting deep vein thrombosis, thus resulting in market growth. The Global Deep Vein Thrombosis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Deep Vein Thrombosis Market Definition

Deep Vein Thrombosis (DVT) is defined as the formation of blood clots (also called thrombosis) inside a deep vein in the body. The condition mainly occurs in the legs, however, it may occur in the arms and pelvic areas. It can lead to complete or partial blockage of circulation which usually leads to medical problems. This condition altogether is called venous thromboembolism (VTE), which might be fatal and can possibly lead to death. Thus, VTE is required to be tackled on time.

There are various treatment devices including thrombectomy systems, compression devices, and filters among others which are used to treat VTE, and with increasing disease prevalence, their acceptance will possibly spur in the coming years. There is a rising pervasiveness of cancer and cardiovascular diseases (CVD) owing to the adoption of alcohol, smoking, consumption of high-cholesterol food, lack of physical activity, and increasing obesity rate. Vascular diseases and cancer patients pose a high risk of contracting deep vein thrombosis (DVT). Cancer patients have a higher possibility of forming blood clots with treatment procedures together with associated heredity.

Global Deep Vein Thrombosis Market Overview

VTE is a possibly dangerous condition and if it is not treated at the proper time, it may result in complications and death. According to the Centres for Disease Control and Prevention (CDC), about 60,000-100,000 people in the U.S. die due to deep vein thrombosis. Also, blood clots are primarily and usually managed by drug therapy. But, sometimes, patients may need surgical intervention and mechanical devices to treat and manage the condition more efficiently.

Thus, with market leaders launching novel devices, the end-users will have a wider range of treatment options, thus presenting lucrative development opportunities over the forecast period. Thus, complications resulting from stent placement may restrict the market expansion to some extent. Also, side effects caused due to thrombosis drugs will limit the market and lack of patient awareness regarding deep vein thrombosis conditions will hinder the market development of global deep vein thrombosis.

Increasing research and development activities by key market players and increasing funding from the government in developed nations will significantly boost the Deep Vein Thrombosis Market demand over the coming years. In addition, growing focus on drug development, growing demand for precision medicine, high adoption of point-of-care diagnostics and home care settings, and rising investments in research and development activities are anticipated to drive global market revenue growth over the forecast period.

Global Deep Vein Thrombosis Market Segmentation Analysis

The Global Deep Vein Thrombosis Market is Segmented on the basis of Treatment, Distribution Channel, And Geography.

Deep Vein Thrombosis Market, By Treatment

• Clot Busters
• Blood Thinners
• Inferior Vena Cava Filters
• Compression Stockings
• Others

Based on Treatment, The market is bifurcated into Clot Busters, Blood Thinners, Inferior Vena Cava Filters, Compression Stockings, Others. Blood thinners accounted for a significant market share. These medicines, also known as anticoagulants, help avoid blood clots from growing bigger. There are several different types of blood-thinning drugs employed to treat DVT. Blood thinners lessen the risk of developing additional clots. Blood thinners may be administered by mouth or administered by IV or an injection under the skin.

Deep Vein Thrombosis Market, By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• E-commerce

Based on Distribution Channel, The market is bifurcated into Retail Pharmacy, Hospital Pharmacy, and E-commerce. Hospital pharmacies accounted for the largest market share in 2021. Hospital pharmacies provide several benefits, such as easier availability of medicines. With a greater number of medical professionals and advanced infrastructure, a substantial part of CVD patients visits hospital OPDs to avail of treatment along with drug prescriptions. As more patients choose to get treatments at hospitals to advantage of high-quality care, drug sales across in-house pharmacies will expand at a considerable pace.

Deep Vein Thrombosis Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Regional Analysis, The Global Deep Vein Thrombosis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the largest market in the global Deep Vein Thrombosis market. According to the American Medical Association, about 2 million Americans have contracted deep vein thrombosis annually. Therefore, with the growing incidence of a such fatal disease, its diagnosis, awareness, and timely treatment is crucial. Numerous organizations are taking initiatives to increase awareness about VTE in the nation. Some organizations, in partnership with the CDC, are connecting the ‘Stop the Clot, Spread the Word’ campaign to spread national awareness regarding blood clots. Such initiatives will positively influence knowledge regarding disease diagnosis and treatment substitutes, thus influencing the market value over the forecast timeline.

Key Players

The “Global Deep Vein Thrombosis Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Bristol-Myers Squibb Company, Pfizer, Sanofi-Aventis, Daiichi Sankyo Co. Ltd., Medtronic plc, Johnson & Johnson, and others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In April 2021, Valeo Pharmaceuticals announced the commencement of commercial shipments of Redesca and Redesca HP, which are Heparin and low-molecular-weight Heparin used in treating deep vein thrombosis as blood thinners.

• In June 2021, FDA approved first oral blood thinner, called Pradaxa (dabigatran etexilate) to treat children of age 3 months to 12 years with DVT.

• In December 2020, Natco Pharma announced to launch Rivaroxaban molecule under brand name RPIGAT, in India which is used to treat and prevent blood clots.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Deep Vein Thrombosis market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in global Deep Vein Thrombosis market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Research Methodology of Market Research